Breaking News, Financial News

Financial Report: Thermo Fisher Scientific

Revenues up 6% in the quarter

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Thermo Fisher Scientific 4Q Revenues: $3.3 billion (+6%) 4Q Earnings: $376.4 million (+12%) FY Revenues: $12.5 billion (+8%) FY Earnings: $1.2 billion (+9%) Comments: Analytical Technologies Segment revenue was up 2% to $1.1 billion in the quarter. Specialty Diagnostics Segment revenue increased 12% to $792 million. Laboratory Products and Services Segment revenue increased 4% to $1.5 billion....

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters